Elkayam U - Search Results

1

Assessment of renal hemodynamic effects of nesiritide in patients with heart failure using intravascular Doppler and quantitative angiography.

Elkayam U, Akhter MW, Liu M, Hatamizadeh P, Barakat MN. Elkayam U, et al. JACC Cardiovasc Imaging. 2008 Nov;1(6):765-71. doi: 10.1016/j.jcmg.2008.07.013. JACC Cardiovasc Imaging. 2008. PMID: 19356514 Free article. Clinical Trial.

2

Impaired endothelium-mediated vasodilation in heart failure: clinical evidence and the potential for therapy.

Elkayam U, Khan S, Mehboob A, Ahsan N. Elkayam U, et al. J Card Fail. 2002 Feb;8(1):15-20. doi: 10.1054/jcaf.2002.31910. J Card Fail. 2002. PMID: 11862578 Review.

3

Nesiritide: a new drug for the treatment of decompensated heart failure.

Elkayam U, Akhter MW, Tummala P, Khan S, Singh H. Elkayam U, et al. J Cardiovasc Pharmacol Ther. 2002 Jul;7(3):181-94. doi: 10.1177/107424840200700308. J Cardiovasc Pharmacol Ther. 2002. PMID: 12232567 Review.

4

Hemodynamic and clinical effects of tezosentan, an intravenous dual endothelin receptor antagonist, in patients hospitalized for acute decompensated heart failure.

Torre-Amione G, Young JB, Colucci WS, Lewis BS, Pratt C, Cotter G, Stangl K, Elkayam U, Teerlink JR, Frey A, Rainisio M, Kobrin I. Torre-Amione G, et al. Among authors: elkayam u. J Am Coll Cardiol. 2003 Jul 2;42(1):140-7. doi: 10.1016/s0735-1097(03)00556-4. J Am Coll Cardiol. 2003. PMID: 12849674 Free article. Clinical Trial.

5

Comparison of effects on left ventricular filling pressure of intravenous nesiritide and high-dose nitroglycerin in patients with decompensated heart failure.

Elkayam U, Akhter MW, Singh H, Khan S, Usman A. Elkayam U, et al. Am J Cardiol. 2004 Jan 15;93(2):237-40. doi: 10.1016/j.amjcard.2003.09.051. Am J Cardiol. 2004. PMID: 14715359 Clinical Trial.

6

Effect of elevated admission serum creatinine and its worsening on outcome in hospitalized patients with decompensated heart failure.

Akhter MW, Aronson D, Bitar F, Khan S, Singh H, Singh RP, Burger AJ, Elkayam U. Akhter MW, et al. Among authors: elkayam u. Am J Cardiol. 2004 Oct 1;94(7):957-60. doi: 10.1016/j.amjcard.2004.06.041. Am J Cardiol. 2004. PMID: 15464689

7

Intravenous nitroglycerin in the treatment of decompensated heart failure: potential benefits and limitations.

Elkayam U, Bitar F, Akhter MW, Khan S, Patrus S, Derakhshani M. Elkayam U, et al. J Cardiovasc Pharmacol Ther. 2004 Dec;9(4):227-41. doi: 10.1177/107424840400900403. J Cardiovasc Pharmacol Ther. 2004. PMID: 15678242 Review.

8

Effects of nitrates and hydralazine in heart failure: clinical evidence before the african american heart failure trial.

Elkayam U, Bitar F. Elkayam U, et al. Am J Cardiol. 2005 Oct 10;96(7B):37i-43i. doi: 10.1016/j.amjcard.2005.07.031. Epub 2005 Aug 9. Am J Cardiol. 2005. PMID: 16226934 Review.

9

Variable response of conductance and resistance coronary arteries to endothelial stimulation in patients with heart failure due to nonischemic dilated cardiomyopathy.

Bitar F, Lerman A, Akhter MW, Hatamizadeh P, Janmohamed M, Khan S, Elkayam U. Bitar F, et al. Among authors: elkayam u. J Cardiovasc Pharmacol Ther. 2006 Sep;11(3):197-202. doi: 10.1177/1074248406292574. J Cardiovasc Pharmacol Ther. 2006. PMID: 17056833

10

Use and impact of inotropes and vasodilator therapy in hospitalized patients with severe heart failure.

Elkayam U, Tasissa G, Binanay C, Stevenson LW, Gheorghiade M, Warnica JW, Young JB, Rayburn BK, Rogers JG, DeMarco T, Leier CV. Elkayam U, et al. Am Heart J. 2007 Jan;153(1):98-104. doi: 10.1016/j.ahj.2006.09.005. Am Heart J. 2007. PMID: 17174645

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

283 results

Search Page

Filters